The potential of CO<sub>2</sub>-based production cycles in biotechnology to fight the climate crisis.
Where this comes from
- Record sourced from PubMed, PMID 37914683.
- Also identified by DOI 10.1038/s41467-023-42790-6 and PMC identifier 10620168.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Rising CO<sub>2</sub> emissions have pushed scientists to develop new technologies for a more sustainable bio-based economy. Microbial conversion of CO<sub>2</sub> and CO<sub>2</sub>-derived carbon substrates into valuable compounds can contribute to carbon neutrality and sustainability. Here, we discuss the potential of C1 carbon sources as raw materials to produce energy, materials, and food and feed using microbial cell factories. We provide an overview of potential microbes, natural and synthetic C1 utilization pathways, and compare their metabolic driving forces. Finally, we sketch a future in which C1 substrates replace traditional feedstocks and we evaluate the costs associated with such an endeavor.
Medical subject headings
- Carbon Dioxide
- Biotechnology